Key Takeaway: SBC Medical Group Holdings has reported strong financial results for the second quarter of 2026. The company experienced a 13% increase in revenue compared to the previous year, alongside a remarkable 335% rise in net income. Additionally, adjusted EBITDA grew by 32%, reflecting a successful restructuring and reacceleration of growth.
Price reaction · baseline $3.2 (2026-08-12 close) · hit pre-market · 2 other SBC headline(s) in the window, move may be shared
day 0 close
-0.3%
Market Sentiment Analysis
POSITIVE FACTORS
Q2 revenue increased by 13% year-over-year.
Net income saw a significant rise of 335%.
Adjusted EBITDA rose by 32%, indicating strong operational performance.
Full Press Release Details
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.
Frequently Asked Questions
What was the revenue growth for SBC in Q2 2026?
SBC Medical Group reported a 13% increase in revenue for Q2 2026.
How much did SBC's net income increase?
Net income for SBC Medical Group surged by 335% year-over-year.
What was the adjusted EBITDA growth for SBC?
Adjusted EBITDA rose by 32% compared to the previous year.